Gradient Investments LLC Sells 38,199 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Gradient Investments LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 50.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,924 shares of the healthcare conglomerate’s stock after selling 38,199 shares during the quarter. Gradient Investments LLC’s holdings in UnitedHealth Group were worth $19,479,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Advocacy Wealth Management Services LLC grew its stake in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its stake in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares during the period. Rise Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $38,000. Evolution Advisers Inc. acquired a new position in UnitedHealth Group in the first quarter valued at about $38,000. Finally, Cordant Inc. acquired a new position in shares of UnitedHealth Group during the first quarter worth about $45,000. Institutional investors own 87.25% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Sanford C. Bernstein cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price objective for the company. in a research report on Thursday, May 26th. They noted that the move was a valuation call. Mizuho upped their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research report on Thursday, September 8th. Morgan Stanley increased their price target on UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Finally, Loop Capital began coverage on UnitedHealth Group in a research report on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $585.65.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares in the company, valued at approximately $4,043,896. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Dirk C. Mcmahon sold 14,715 shares of the firm’s stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $543.32, for a total value of $7,994,953.80. Following the completion of the sale, the chief executive officer now directly owns 50,108 shares in the company, valued at approximately $27,224,678.56. The disclosure for this sale can be found here. Insiders have sold a total of 140,324 shares of company stock worth $75,086,185 in the last 90 days. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $521.02 on Monday. The firm has a market capitalization of $487.35 billion, a price-to-earnings ratio of 27.21, a P/E/G ratio of 1.63 and a beta of 0.76. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The stock’s 50 day moving average price is $529.29 and its two-hundred day moving average price is $511.81.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter last year, the company earned $4.70 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be paid a dividend of $1.65 per share. The ex-dividend date is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.27%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also



Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *